These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7597302)

  • 1. Clinical activity of a polyvalent melanoma antigen vaccine.
    Bystryn JC
    Recent Results Cancer Res; 1995; 139():337-48. PubMed ID: 7597302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival of patients with melanoma with an antibody response to immunization to a polyvalent melanoma vaccine.
    Miller K; Abeles G; Oratz R; Zeleniuch-Jacquotte A; Cui J; Roses DF; Harris MN; Bystryn JC
    Cancer; 1995 Jan; 75(2):495-502. PubMed ID: 7812920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immune response to a therapeutic polyvalent cancer vaccine after complete resection of thick primary melanoma and sentinel lymphadenectomy.
    Chung MH; Gupta RK; Hsueh E; Essner R; Ye W; Yee R; Morton DL
    J Clin Oncol; 2003 Jan; 21(2):313-9. PubMed ID: 12525524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: an immunologic survival model.
    Jones RC; Kelley M; Gupta RK; Nizze JA; Yee R; Leopoldo Z; Qi K; Stern S; Morton DL
    Ann Surg Oncol; 1996 Sep; 3(5):437-45. PubMed ID: 8876885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial.
    Wallack MK; Sivanandham M; Balch CM; Urist MM; Bland KI; Murray D; Robinson WA; Flaherty L; Richards JM; Bartolucci AA; Rosen L
    J Am Coll Surg; 1998 Jul; 187(1):69-77; discussion 77-9. PubMed ID: 9660028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind trial of a polyvalent, shed-antigen, melanoma vaccine.
    Bystryn JC; Zeleniuch-Jacquotte A; Oratz R; Shapiro RL; Harris MN; Roses DF
    Clin Cancer Res; 2001 Jul; 7(7):1882-7. PubMed ID: 11448900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to postsurgical adjuvant active immunotherapy with Canvaxin polyvalent cancer vaccine: correlations with clinical course of patients with metastatic melanoma.
    Morton DL
    Dev Biol (Basel); 2004; 116():209-17; discussion 229-36. PubMed ID: 15603194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma.
    Bystryn JC; Oratz R; Roses D; Harris M; Henn M; Lew R
    Cancer; 1992 Mar; 69(5):1157-64. PubMed ID: 1739915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of a polyvalent human melanoma antigen vaccine.
    Bystryn JC; Jacobsen S; Harris M; Roses D; Speyer J; Levin M
    J Biol Response Mod; 1986 Jun; 5(3):211-24. PubMed ID: 3723138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous melanoma vaccine induces antitumor and self-reactive immune responses that affect patient survival and depend on MHC class II expression on vaccine cells.
    Lotem M; Machlenkin A; Hamburger T; Nissan A; Kadouri L; Frankenburg S; Gimmon Z; Elias O; David IB; Kuznetz A; Shiloni E; Peretz T
    Clin Cancer Res; 2009 Aug; 15(15):4968-77. PubMed ID: 19602547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of cyclophosphamide on the immunogenicity of a melanoma antigen vaccine.
    Oratz R; Dugan M; Roses DF; Harris MN; Speyer JL; Hochster H; Weissman J; Henn M; Bystryn JC
    Cancer Res; 1991 Jul; 51(14):3643-7. PubMed ID: 2065322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and clinical activity of a polyvalent melanoma antigen vaccine prepared from shed antigens.
    Bystryn JC
    Ann N Y Acad Sci; 1993 Aug; 690():190-203. PubMed ID: 8368738
    [No Abstract]   [Full Text] [Related]  

  • 13. Melanoma vaccines: what we know so far.
    Bystryn JC; Reynolds SR
    Oncology (Williston Park); 2005 Jan; 19(1):97-108; discussion 108, 111-2, 115. PubMed ID: 15743154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine.
    Hsueh EC; Morton DL
    Semin Cancer Biol; 2003 Dec; 13(6):401-7. PubMed ID: 15001158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of melanoma antigens that are immunogenic in humans and expressed in vivo.
    Applebaum J; Reynolds S; Knispel J; Oratz R; Shapiro R; Bystryn JC
    J Natl Cancer Inst; 1998 Jan; 90(2):146-9. PubMed ID: 9450575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine.
    Hsueh EC; Gupta RK; Qi K; Morton DL
    J Clin Oncol; 1998 Sep; 16(9):2913-20. PubMed ID: 9738558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of immunogenic human melanoma antigens in a polyvalent melanoma vaccine.
    Bystryn JC; Henn M; Li J; Shroba S
    Cancer Res; 1992 Nov; 52(21):5948-53. PubMed ID: 1382848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine.
    Hsueh EC; Essner R; Foshag LJ; Ollila DW; Gammon G; O'Day SJ; Boasberg PD; Stern SL; Ye X; Morton DL
    J Clin Oncol; 2002 Dec; 20(23):4549-54. PubMed ID: 12454111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of melanoma vaccines.
    Kuhn CA; Hanke CW
    Dermatol Surg; 1997 Aug; 23(8):649-54; discussion 654-5. PubMed ID: 9256911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune response to intralymphatic immunotherapy for disseminated melanoma: correlation with clinical response.
    Ahn SS; Irie RF; Weisenburger TH; Jones PC; Juillard G; Roe DJ; Morton DL
    Surgery; 1982 Aug; 92(2):362-7. PubMed ID: 7101129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.